Supply chains facing major challenges

At the 4th Global Pharma Supply Chain Congress 2019, the BME expects around 200 international supply chain top managers from the pharmaceutical, medical technology, biotechnology and generics sectors to attend.

Will also give the opening speech in 2019: BME Managing Director Dr. Silvius Grobosch. Photo: Jochen Günther/BME e.V.

From 11 to 14 February 2019, the German Association for Supply Chain Management, Procurement and Logistics (Bundesverband Materialwirtschaft, Einkauf und Logistik e.V., BME) will be hosting the 4th BME-Global Pharma Supply Chain Congress at the Marriott Hotel in Frankfurt. “The English-language specialist event is aimed at selected supply chain top executives from the pharmaceutical and medtech industries as well as top-class representatives of international public and private organisations and institutions,” explains BME Managing Director Dr. Silvius Grobosch. Globalization and digitization also left their mark on the international pharmaceutical supply chains. These are faced with major challenges. For this reason, the congress aims to create a platform that examines all links in the supply chain in more detail. “At the same time, we want to use this event to promote joint work on innovative supply chain models,” says Grobosch, who will open the four-day congress on 12 February.

Unlike last year, the 4th BME Global Pharma Supply Chain Congress will once again pay greater attention to the important topic of global health. Speeches by renowned NGOs and institutions such as the Bill & Melinda Gates Foundation, the Clinton Health Initiative as well as the Global Fund to Fight Aids, Tuberculosis and Malaria and the World Economic Forum are planned.

There will be no specific country focus in 2019. The congress will focus on case studies and process-driven presentations to highlight the potential transferability to the economic sector. In Frankfurt, topics will also be discussed that are important not only for global players but also for SMEs.

As in previous years, high-ranking keynote speakers will address the plenary on the megatrends in global pharmaceutical supply chains: Arnaud Bernaert, member of the Executive Committee of the World Economic Forum in Geneva, talks about “The complexity of the modern world, trends for the future and what this means for the pharmaceutical industry”.“The end-to-end supply chain: goals beyond visibility" is the topic of a lecture by Declan Supple, VP Global Supply Chain of the STADA Group. Further program information is available at www.bme.de/en/all-events/4th-global-pharma-supply-chain-congress/

The opening plenary session will be followed by several expert forums on topics such as “Global End to End Supply Chain Management”, “Technology and Innovation” and “Processes and People”.

In the late afternoon of the first day of the congress, a Solution Forum will follow, attended by managers from Boehringer Ingelheim and Grünenthal, among others.

In addition to the event program, plant tours are planned at Boehringer Ingelheim, Amazon Koblenz and Panalpina in Weiterstadt. In addition, start-ups will present their solutions at the end of the event in short pitches.

The symposium is Europe's only peer for peer event for executives in supply chain management in the pharmaceutical and medical technology industries. The BME will also be supported by a steering committee in the planning and implementation of the event in 2019. The expert committee consists of 12 high-ranking supply chain managers from leading global pharmaceutical and healthcare companies.

For further information: sarah.baer(at)bme.de

Social Media